Cannabis finance news

Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3

by Steve Jones April 21, 2026April 21, 2026

Medicinal cannabis and psychedelic manufacturer Bioxyne reported revenue of $21.3 million in the three months ending […]

LGP delays shareholder vote on Cannatrek deal as conditions ‘remain outstanding’

by Steve Jones April 21, 2026June 8, 2026

Cannabiz Awards 2026 launch with three new categories and 12 new judges

by cannabiz team April 16, 2026June 8, 2026

Epsilon Healthcare and former chairman settle legal dispute

by Steve Jones April 14, 2026April 14, 2026

Cannatrek shareholders approve merger with Little Green Pharma

by Steve Jones April 10, 2026April 10, 2026

Former Althea CEO Josh Fegan accuses firm of breach of contract

by Steve Jones April 7, 2026April 7, 2026

TGA still investigating Cannatrek, merger document states, as dates set for key shareholder votes

by Steve Jones March 26, 2026March 26, 2026

We just couldn’t grow fast enough, Helius CEO reveals amid warning for firms to be ‘realistic’

by Adam Sheldon March 26, 2026March 26, 2026

The People’s Plant pushes toward $1.5m as CSF offer nears close

by Adam Sheldon March 19, 2026March 19, 2026

Cash shortage offers only ‘limited window’ to sell Helius, administrator tells creditors

by Steve Jones March 18, 2026March 18, 2026